For Quick Alerts
For Daily Alerts

Aurobindo rallies 5 per cent following stellar Q3 results

Aurobindo rallies 5 per cent following stellar Q3 results
Aurobindo Pharma: Quotes, News
BSE 514.10BSE Quote13.05 (2.54%)
NSE 516.15NSE Quote15.05 (2.92%)
Shares in Aurobindo Pharma jumped 5 per cent in trade after the company reported a good set of results for Q3 2013.

The stock was last trading at Rs 518.10, following a four fold jump in net profit. Aurobindo Pharma reported a net profit of Rs 417 crores, which was a new record for the company.

Revenues grew 81 per cent to Rs 2140, led by strong growth in the US markets.

Aurobindo Pharma is the market leader in Semi-Synthetic Penicillins and has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

Read more about: aurobindo pharma
Story first published: Friday, February 7, 2014, 10:56 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more